BOC Sciences Offers Pseudouridine and Its Derivatives for RNA Improvement

Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure

Biofourmis completed a proof of concept study for its heart failure digital therapeutic BiovitalsHF that met its endpoint of number of patients at 50% of optimal therapy. As a result, FDA has granted the DTx the first-ever Breakthrough Designation for a heart failure digital therapy.

Cisco fixes vulnerability that allowed criminals to remotely execute arbitrary code and control a firewall

Positive Technologies researchers discovered a vulnerability in Cisco Firepower Device Manager On-Box – a product designed to locally configure Cisco Firepower firewalls. Now patched, the flaw could allow attackers to gain full control over the device and its capabilities. That could include handing over to criminals the ability to filter traffic. Attackers could also shut down a firewall, or even access other internal resources within an enterprise, if they’re located on the same subnet.

Sensyne grows medical research dataset to 60 million patients

Deep longitudinal, disease agnostic structured global dataset, covering over 4,000 indications will industrialize Sensyne’s life sciences activities

Stelis Biopharma appoints Mark W. Womack as the new CEO

Amerigo Scientific Launches New AcrB Transporter for Therapeutic Indications

Amerigo Scientific recently launches AcrB transporter that aids in the identification, development, refinement, and validation of new molecules and therapeutic antibodies.

Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization

Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the execution of a definitive agreement to acquire Solentim, a trusted global leader of solutions for the isolation and characterization of high value single cell clones in cell line development (CLD) applications.

BIO-ISAC founded to protect and build resilience from increasing attacks on public and private bioeconomy infrastructure

DNAnexus Platform Exceeds Online Security Standards in President Biden’s Executive Order Aimed at Protecting American Infrastructure from Cyberattacks

DNAnexus platform exceeds online security policy objectives outlined in President Biden’s executive order protecting American infrastructure from cyberattacks

FDB Launches Clinical Decision Support Analytics Solution

FDB Launches Clinical Decision Support Analytics Solution

Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics

Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics

Heraeus completes multi-million Euro cancer therapy API capacity expansion

Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany.

Dotmatics to deliver the foundation for Croda’s R&D digital program: artificial intelligence and data mining

For further information on Dotmatics, please visit www.dotmatics.com

Quanticate appoints new Head of Machine Learning and Digital Transformation

Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Piotr Karasiewicz as the company's new Head of Machine Learning and Digital Transformation to lead process improvements and ensure efficient and high-quality data analysis.

1upHealth Announces Free Baseline Testing for Health Plans to Determine if their Patient Access FHIR® API is Successfully Connecting as Required by CMS

Panthera steps up its move into oncology trials with more than 12 trials in the pipeline and a prostate trial underway

Many cancer clinical research trials were put on hold during Covid – now Panthera Biopartners and Rutherford Health are working in partnership to accelerate oncology research in order to provide improved care for patients.

ADVANZ PHARMA partners with Ashfield Engage to deliver talent acquisition strategy for European specialty medicine division

Ashfield Engage, part of UDG Healthcare plc, announced that it has partnered with ADVANZ PHARMA to develop and deliver a pan-European talent acquisition programme for ADVANZ PHARMA’s specialty medicine division.

Qlucore and Clarivate partner to provide researchers with powerful and flexible omics data analysis and visualization

Researchers will be able to make faster and more accurate analysis of experiment data with a workflow powered by Qlucore Omics Explorer and MetaCore™, a Cortellis™ solution.

StageZero Life Sciences Signs Definitive Agreement with Health Clinics Limited

StageZero Life Sciences, the company that created the first-ever test that simultaneously screens for multiple cancers from a single sample of blood, has acquired Care Oncology. Care Oncology has clinics in California, telehealth practices in all 50 states and provides treatments that complement and enhance the effect of standard-of-care cancer therapies. This acquisition expands StageZero’s clinical offerings, including access to a robust network of oncologists and physicians across the U.S.

Partek and Agilent Partner to Deliver Alissa Customers End-to-End Bioinformatics Workflow: Delivering flexible and customizable secondary analysis and disease diagnoses for the clinical setting

Partek® Flow® bioinformatics software to be integrated into Agilent Alissa Clinical Informatics Platform to deliver a complete end-to-end analysis.